These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7522624)
41. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Hsu SM; Xie SS; Hsu PL; Waldron JA Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458 [TBL] [Abstract][Full Text] [Related]
42. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717 [TBL] [Abstract][Full Text] [Related]
43. Pathophysiology of Hodgkin's disease: functional and molecular aspects. Gruss HJ; Kadin ME Baillieres Clin Haematol; 1996 Sep; 9(3):417-46. PubMed ID: 8922238 [TBL] [Abstract][Full Text] [Related]
44. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma. Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185 [TBL] [Abstract][Full Text] [Related]
45. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Carbone A; Gloghini A; Gruss HJ; Pinto A Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367 [TBL] [Abstract][Full Text] [Related]
46. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910 [TBL] [Abstract][Full Text] [Related]
47. In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease. Xerri L; Birg F; Guigou V; Bouabdallah R; Poizot-Martin I; Hassoun J Int J Cancer; 1992 Mar; 50(5):689-93. PubMed ID: 1312061 [TBL] [Abstract][Full Text] [Related]
48. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409 [TBL] [Abstract][Full Text] [Related]
49. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hsu SM; Lin J; Xie SS; Hsu PL; Rich S Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031 [TBL] [Abstract][Full Text] [Related]
50. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Zheng B; Georgakis GV; Li Y; Bharti A; McConkey D; Aggarwal BB; Younes A Clin Cancer Res; 2004 May; 10(9):3207-15. PubMed ID: 15131062 [TBL] [Abstract][Full Text] [Related]
51. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells. Heuser C; Diehl V; Abken H; Hombach A Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650 [TBL] [Abstract][Full Text] [Related]
52. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. Lee SP; Constandinou CM; Thomas WA; Croom-Carter D; Blake NW; Murray PG; Crocker J; Rickinson AB Blood; 1998 Aug; 92(3):1020-30. PubMed ID: 9680372 [TBL] [Abstract][Full Text] [Related]
53. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Kim SH; Shin YK; Lee IS; Bae YM; Sohn HW; Suh YH; Ree HJ; Rowe M; Park SH Blood; 2000 Jan; 95(1):294-300. PubMed ID: 10607715 [TBL] [Abstract][Full Text] [Related]
54. The role of CD40 ligand in costimulation and T-cell activation. Grewal IS; Flavell RA Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720 [TBL] [Abstract][Full Text] [Related]
55. Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells. Hsu SM; Hsu PL Am J Pathol; 1990 Sep; 137(3):563-74. PubMed ID: 1698024 [TBL] [Abstract][Full Text] [Related]
56. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells? Hsu SM; Hsu PL Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402 [TBL] [Abstract][Full Text] [Related]
57. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment. Rinaldi I Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526 [TBL] [Abstract][Full Text] [Related]
58. Functional CD40 ligand is expressed on epidermal Langerhans cells. Salgado CG; Nakamura K; Sugaya M; Tada Y; Asahina A; Koyama Y; Irie S; Tamaki K J Leukoc Biol; 1999 Aug; 66(2):281-5. PubMed ID: 10449168 [TBL] [Abstract][Full Text] [Related]
59. Diagnostic significance of CD40, CD40L, and CD26 expression in Hodgkin's disease and other lymphomas. Carbone A; Gloghini A Am J Clin Pathol; 1996 Apr; 105(4):522-3. PubMed ID: 8604696 [No Abstract] [Full Text] [Related]
60. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]